Prosthetic Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Prosthetic Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Prosthetic Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Prosthetic Heart Valves pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Prosthetic heart valves are a device which mimics the function of human heart valves and have a passive mode of functioning; opening and closing of valves are responses to pressure and flow changes within the heart. Prosthetic heart valves are for the patients that have a heart valvular disease where they need their valve to be replaced.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Prosthetic Heart Valves under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Prosthetic Heart Valves and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Prosthetic Heart Valves under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
Introduction
Prosthetic Heart Valves Overview
Products under Development
Prosthetic Heart Valves - Pipeline Products by Stage of Development
Table Prosthetic Heart Valves - Pipeline Products by Stage of Development
Table Prosthetic Heart Valves - Pipeline Products by Stage of Development
Prosthetic Heart Valves - Pipeline Products by Segment
Table Prosthetic Heart Valves - Pipeline Products by Segment
Table Prosthetic Heart Valves - Pipeline Products by Segment
Prosthetic Heart Valves - Pipeline Products by Territory
Table Prosthetic Heart Valves - Pipeline Products by Territory
Table Prosthetic Heart Valves - Pipeline Products by Territory
Prosthetic Heart Valves - Pipeline Products by Regulatory Path
Table Prosthetic Heart Valves - Pipeline Products by Regulatory Path
Table Prosthetic Heart Valves - Pipeline Products by Regulatory Path
Prosthetic Heart Valves - Pipeline Products by Estimated Approval Date
Table Prosthetic Heart Valves - Pipeline Products by Estimated Approval Date
Table Prosthetic Heart Valves - Pipeline Products by Estimated Approval Date
Table CGuard Prime - An EFS to Evaluate the Safety and Preliminary Effectiveness of the CGuard Prime Carotid Stent Placement in the Procedure Setting of Acute Ischemic Stroke
JC Medical, Inc. Company Overview
JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table J-Valve TF Delivery System - Product Description
Table JC Medical, Inc. - Ongoing Clinical Trials Overview
Table J-Valve TF Delivery System - Efficacy and Safety of the J-Valve Transcatheter Aortic Valve Replacement System in Patients With Aortic Stenosis Disease
Jinshi Biotechnology (Changshu) Co Ltd Company Overview
NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table ValveClip-M - Product Status
Table ValveClip-M - Product Description
Table ValveClip-T - Product Status
Table ValveClip-T - Product Description
Table NewMed Medical Co Ltd - Ongoing Clinical Trials Overview
Table ValveClip-M - Evaluation of the Efficacy and Safety of the Transcatheter Mitral Valve Repair System in Patients with Moderate and Above Degenerative Mitral Regurgitation at High Surgical Risk
Novostia SA Company Overview
Novostia SA Pipeline Products & Ongoing Clinical Trials Overview
Table Novostia SA Pipeline Products & Ongoing Clinical Trials Overview
Table Triflo Valve - Product Status
Table Triflo Valve - Product Description
Table Novostia SA - Ongoing Clinical Trials Overview
Table Triflo Valve - A First-in-Human (FIH) Trial of Artificial Heart Valve for the Treatment of Heart Valve Diseases
Table Triflo Valve - A Pilot Study of Artificial Heart Valve for the treatment of Heart Valve Diseases
Table Triflo Valve - A Pivotal Study of Artificial Heart Valve for the treatment of Heart Valve Diseases
Table Triflo Valve - A Prospective, Single-arm, Exploratory Clinical Investigation to Assess Preliminary Safety and Collect Performance and Effectiveness Data of the TRIFLO Heart Valve
Ohio State University Company Overview
Ohio State University Pipeline Products & Ongoing Clinical Trials Overview
Table Ohio State University Pipeline Products & Ongoing Clinical Trials Overview
Table Topaz Tricuspid Valve Replacement (TTVR) System - A Pivotal Study to Evaluate the Efficacy of Topaz Tricuspid Valve Replacement (TTVR) System Treatment in Subjects with Tricuspid Regurgitation
Table Topaz Tricuspid Valve Replacement (TTVR) System - The TRICURE EFS Tricares Topaz Transfemoral Tricuspid Heart Valve Replacement System Early Feasibility Study
Table Topaz Tricuspid Valve Replacement (TTVR) System - TRiCares Topaz Transfemoral Tricuspid Heart Valve Replacement System First In Human Trial
Table Xeltis AG - Ongoing Clinical Trials Overview
Table Xeltis Pulmonary Valve - Prospective, Non-randomized, Pivotal Study to Assess the Safety and Efficacy of the Bioabsorbable Pulmonary Valved Conduit in Subjects Undergoing Right Ventricular Outflow Tract (RVOT) Reconstruction
Prosthetic Heart Valves- Recent Developments
Jun 20, 2024: DurAVR THV First-in-Human Data Confirms Optimal Valve Positioning with the ComASUR Delivery System
Jun 13, 2024: Medtronic Confirms Global Layoffs
May 08, 2024: Medtronic Receives Additional Humanitarian Device Exemption (HDE) clearance for Contegra Pulmonary Valved Conduit
Apr 22, 2024: Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management
Apr 05, 2024: RUA Life Sciences : Business Update
Mar 26, 2024: InspireMD Announces Abstract of One-Year Follow-Up Results from the CGUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024
Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
Mar 04, 2024: LivaNova to Present at the Barclays Global Healthcare Conference
Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
Jan 31, 2024: InspireMD Receives CE Mark Recertification Under EU's New Medical Device Regulation (MDR) Regulatory Framework
Jan 31, 2024: New Heart Treatment Helps the Body Grow a Replacement Valve
Nov 30, 2023: RUA Life Sciences Plans USD4.8 Million Total Equity Raise
Nov 01, 2023: InspireMD Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial at VIVA23
Oct 27, 2023: Edwards receives CE Mark for MITRIS RESILIA valve
Oct 24, 2023: Genesis MedTech begins patient enrolment in J-Valve TF system trial
Oct 19, 2023: Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results
Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference